Association of C‐MYC amplification with progression from the in situ to the invasive stage in C‐MYC‐amplified breast carcinomas

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pathology

• Publication date

  2003-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.1385PMID 12950019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.

  2002influential reference
• C-myc oncogene amplification in ductal carcinoma in situ of the breast

  2002cited by this paper
• Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc

  2001cited by this paper
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ

  2001cited by this paper
• Detection of Gene Amplification in Intraductal and Infiltrating Breast Cancer by Laser-Assisted Microdissection and Quantitative Real-Time PCR

  2001influential reference
• Deregulated expression of c-Myc depletes epidermal stem cells

  2001cited by this paper
• C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

  2000cited by this paper
• Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins

  2000cited by this paper
• Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: Relation to morphology, cell proliferation and expression of breast cancer‐related genes

  2000cited by this paper
• The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma

  2000cited by this paper
• Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.

  2000cited by this paper
• Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors

  2000cited by this paper
• Direct activation of TERT transcription by c-MYC

  1999cited by this paper
• 20q13.2 Amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast

  1999cited by this paper
• Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

  1999influential reference
• The transition from hyperplasia to invasive carcinoma of the breast

  1999cited by this paper
• Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways

  1999cited by this paper
• Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes

  1999cited by this paper
• Novel approach to quantitative polymerase chain reaction using real‐time detection: Application to the detection of gene amplification in breast cancer

  1998cited by this paper
• Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

  1998cited by this paper
• Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.

  1997cited by this paper
• Proteins of the Myc network: essential regulators of cell growth and differentiation.

  1996cited by this paper
• Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.

  1995cited by this paper
• Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis.

  1993cited by this paper
• Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

  1992cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Intraductal carcinoma of the breast: Follow‐up after biopsy only

  1982cited by this paper
• Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone.

  1978cited by this paper
• © 1997 Cancer Research Campaign

  year unknowncited by this paper

• Insights into the transition of ductal carcinoma in situ to invasive ductal carcinoma: morphology, molecular portraits, and the tumor microenvironment

  2022cites this paper
• KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway

  2022cites this paper
• Ductal carcinoma in situ of breast: from molecular etiology to therapeutic management.

  2022cites this paper
• Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.

  2021cites this paper
• MMTV-LIKE virus and c-myc over-expression are associated with invasive breast cancer.

  2021cites this paper
• High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer

  2019cites this paper
• How Did We Get There? The Progression from Ductal Carcinoma In Situ to Invasive Ductal Carcinoma

  2019cites this paper
• Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy

  2019cites this paper
• Malignant transformation in a Breast Adenomyoepithelioma Caused by Amplification of c-MYC: A Common pathway to Cancer in a Rare Entity

  2019cites this paper
• Chapter 4 Early-Stage Progression of Breast Cancer

  2018influential citation
• Progression Potential of Ductal Carcinoma in situ Assessed by Genomic Copy Number Profiling

  2018cites this paper
• Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women.

  2018cites this paper
• Using State Space Exploration to Determine How Gene Regulatory Networks Constrain Mutation Order in Cancer Evolution

  2018cites this paper
• Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma

  2018cites this paper
• Inhibiting Myc and the Myc dependent inflammatory response as cancer therapies.

  2017cites this paper
• Investigation of c-Myc gene amplification in breast cancer patients and its correlation with other prognostic factors

  2017cites this paper
• Early-Stage Progression of Breast Cancer

  2017influential citation
• CIP2A is overexpressed in human endometrioid adenocarcinoma and regulates cell proliferation, invasion and apoptosis.

  2017cites this paper
• High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer

  2017cites this paper
• Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells

  2017cites this paper
• MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours

  2016cites this paper
• Molecular Features of Sub type-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer Graphical

  2016cites this paper
• Ductal carcinoma in situ – update on risk assessment and management

  2016cites this paper
• Multiplex Branched DNA Assay zur Untersuchung der Genexpression von Hormonrezeptoren kaniner Mammatumoren und tumorassoziierter Gene in der Zellkultur

  2016cites this paper
• Biomarkers in ductal carcinoma in situ

  2016cites this paper
• Functional effects of ATAD2 gene expression in breast cancer

  2016cites this paper
• The role of the tumour suppressor gene, TP53, in determining breast tumour subtype

  2016cites this paper
• Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma

  2016cites this paper
• Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.

  2016cites this paper
• Role of Genetic Profiling and Recurrence Scores in Treatment Planning for DCIS

  2015cites this paper
• Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential

  2015cites this paper
• Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer

  2015cites this paper
• Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast

  2015cites this paper
• PI 3 K pathway activation in high-grade ductal carcinoma in situ — implications for progression to invasive breast carcinoma

  2014cites this paper
• Quantification of Plasma DNA with Cancer by Real-time PCR

  2014cites this paper
• Pathology and Biological Markers of Invasive Breast Cancer

  2014cites this paper
• CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion

  2014cites this paper
• Human Cancer Biology PI 3 K Pathway Activation in High-Grade Ductal Carcinoma In Situ — Implications for Progression to Invasive Breast Carcinoma

  2014cites this paper
• PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma

  2014cites this paper
• Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment

  2013cites this paper
• Progression from ductal carcinoma in situ to invasive breast cancer: Revisited

  2013cites this paper
• Intracellular trafficking of integrins in cancer cells.

  2013cites this paper
• Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ

  2013cites this paper
• Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

  2012cites this paper
• C-Myc overexpression promotes osteosarcoma cell invasion via activation of MEK-ERK pathway.

  2012cites this paper
• Assessment of palindromes as platforms for DNA amplification in breast cancer.

  2012cites this paper
• FGFR1 is amplified during the progression of in situ to invasive breast carcinoma

  2012cites this paper
• Genomic analysis: toward a new approach in breast cancer management.

  2012cites this paper
• Microarrays in Diagnostics and Biomarker Development: Current and Future Applications

  2012cites this paper
• Tissue Microarrays for Translational Research

  2012cites this paper
• Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma.

  2012cites this paper
• Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma

  2012influential citation
• Immunophenotypic and genomic characterization of papillary carcinomas of the breast

  2012cites this paper
• Analysis of gene expression alterations in premalignant progression from normal mammary epithelium to ductal carcinoma in situ by multiple orthogonal tools

  2012cites this paper
• Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra‐tumour genetic heterogeneity and clonal selection

  2012cites this paper
• C-myc as a predictive marker for chemotherapy in metastatic breast cancer

  2012cites this paper
• Tumorigenesis and Neoplastic Progression Single-Cell Genetic Analysis of Ductal Carcinoma in Situ and Invasive Breast Cancer Reveals Enormous Tumor Heterogeneity yet Conserved Genomic Imbalances and Gain of MYC during Progression

  2012cites this paper
• The Role of the D-element in Myc Biology

  2011cites this paper
• Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.

  2011cites this paper
• MYC Gene Amplification is Often Acquired in Lethal Distant Breast Cancer Metastases of Unamplified Primary Tumors

  2011cites this paper
• Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study

  2011cites this paper
• Gene amplification in ductal carcinoma in situ of the breast

  2010cites this paper
• Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

  2010cites this paper
• Representativity of TMA studies.

  2010cites this paper
• Cell Polarity in Motion: Redefining Mammary Tissue Organization Through EMT and Cell Polarity Transitions

  2010cites this paper
• MYC regulation of a “poor-prognosis” metastatic cancer cell state

  2010cites this paper
• Breast cancer precursors revisited: molecular features and progression pathways

  2010cites this paper
• Noninvasive molecular imaging of c-Myc activation in living mice

  2010cites this paper
• Molecular Differences between Ductal Carcinoma In Situ and Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study

  2010cites this paper
• MYC and Breast Cancer.

  2010cites this paper
• Molecular Pathology of Breast Cancer

  2009cites this paper
• Serum autoantibodies as tumour markers in breast cancer: their role in screening, diagnosis and prognosis

  2009cites this paper
• The significance of the expression of ERRalpha as a potential biomarker in breast cancer.

  2009cites this paper
• ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.

  2009cites this paper
• CSN 5 Isopeptidase Activity Links COP 9 Signalosome Activation to Breast Cancer Progression

  2008cites this paper
• Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies

  2008cites this paper
• Omics‐based profiling of carcinoma of the breast and matched regional lymph node metastasis

  2008cites this paper
• Chromosomal alterations and telomere dysfunction in breast tumours

  2008influential citation
• CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.

  2008cites this paper
• MYC in breast tumor

  2008cites this paper
• Cell cycle machinery: links with genesis and treatment of breast cancer.

  2008cites this paper
• MYC in breast tumor progression

  2008cites this paper
• Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cells

  2007cites this paper
• Pathways to tamoxifen resistance.

  2007cites this paper
• Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer.

  2007cites this paper
• Molecular and Morphologic Distinctions between Infiltrating Ductal and Lobular Carcinoma of the Breast

  2007cites this paper
• MYC amplification and TERT expression in breast tumor progression.

  2007cites this paper
• Notch, Myc and Breast Cancer

  2007cites this paper
• Chromogenic and fluorescent in situ hybridization in breast cancer.

  2007cites this paper
• ERR Gamma: Does an Orphan Nuclear Receptor Link Steroid Hormone Biogenesis to Endocrine Resistance?

  2007cites this paper
• c-myc oncogene aberration in breast cancer patients assessed by direct double differential PCR

  2007cites this paper
• Molecular genetics of ADH/DCIS and ALH/LCIS

  2006cites this paper
• c-myc Amplifications in primary breast carcinomas and their local recurrences

  2006cites this paper
• c-Myc overexpression and endocrine resistance in breast cancer.

  2006cites this paper
• DCIS: Pathology and Molecular Markers

  2006cites this paper
• MYC amplification in breast cancer: a chromogenic in situ hybridisation study

  2006cites this paper
• The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma.

  2006cites this paper
• Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1

  2006cites this paper
• Suppression of Wnt Signaling by the Green Tea Compound (–)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells

  2006cites this paper
• Gene amplification in carcinogenesis

  2006cites this paper